AG
ARA

Aperio Group’s American Renal Associates Holdings, Inc ARA Stock Holding History

Aperio Group’s Portfolio ARA Stock Details ARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-98
Closed -$1K – 2948
2019
Q2 		$1K Buy
+98
New +$646 ﹤0.01% 3006

Other funds holding ARA

CP
Centerbridge Partners New York $61.1M AUM 3.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
WIC
Whitegate Investment Counselors Concord, New Hampshire $315M AUM 10.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Aperio Group's ARA Position: Q3 2019 in Review

Aperio Group sold out of American Renal Associates Holdings, Inc (ARA) in Q3 2019, closing a stake of 98 shares — an estimated $1K sold.

Aperio Group first reported a position in ARA in Q2 2019 and held it in 1 quarter. The position peaked at $1K in Q2 2019. 63 funds tracked by Wall St. Rank hold ARA as of Q3 2019.

  • Aperio Group reported no remaining American Renal Associates Holdings, Inc position as of Q3 2019 after selling out during the quarter.
  • Aperio Group sold 98 American Renal Associates Holdings, Inc shares in Q3 2019, an estimated $1K.
  • Aperio Group first reported a position in American Renal Associates Holdings, Inc in Q2 2019 and held it in 1 quarter.
  • Aperio Group's American Renal Associates Holdings, Inc position peaked at $1K in Q2 2019.
  • 63 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q3 2019.

Based on Aperio Group's 13F filing for Q3 2019, filed 6 Nov 2019.